Recently, the team led by Academician Huang He feng​ of Zhejiang University published landmark findings in Nature. The team successfully constructed the world's first spatiotemporal dynamic transcriptomic atlas of human embryos during the post-gastrulation and early organogenesis stages. This breakthrough resolves a long-standing research challenge in the field, showcasing the cutting-edge scientific capabilities of China's obstetrics and gynecology community to the international academic world, while providing milestone data support for clinical and basic research in birth defect prevention, reproductive medicine, and fetal medicine.

In April 2026, the team led by Academician Jie Qiao​ of Peking University Third Hospital published original research findings in the internationally renowned journal Nature Communications. Based on mouse models, the study is the first to confirm that the endogenous small molecule uridine​ can effectively reverse aging in oocytes and significantly enhance fertility. It elucidates the core mechanism by which uridine targets PCBP1, inhibits ferroptosis, and repairs mitochondrial function. This provides a potentially translatable, China-originated intervention strategy for addressing global female reproductive aging, garnering significant attention in the field of reproductive medicine worldwide.

For patients with moderate to severe intrauterine adhesions, even with standardized surgical treatment, there is still a significant difference in whether pregnancy can be successfully conceived after surgery. A recent study found that the size of the intraoperative intrauterine stent — more accurately an indicator reflecting the intercoronal distance (ICD) — is significantly correlated with clinical pregnancy rates within one year postoperatively. Patients with stent size ≤ XS (corresponding to about 20-22 mm in ICDs) have more than half the chance of clinical pregnancy compared to patients with larger stent size. This study, published in Human Reproduction Open, was completed by Professor Xu Dabao's team at Xiangya Third Hospital of Central South University, and included 560 women with moderate to severe intrauterine adhesions. All patients underwent standardized hysteroscopic treatment, including adhesiolysis, placement of uterine stenting, and planned secondary hysteroscopic examinations. The primary outcome of the study was clinical pregnancy within one year after the last hysteroscopy.

Professor Zheng Ying's team has performed over 1,000 da Vinci Xi multi-port robot-assisted single-port surgeries, among which nearly 600 are for malignant tumors. The quantity and quality of these surgeries rank first in China and among the top globally.

On June 8, the National Health Commission and 14 other ministries jointly released the "Key Points for Correcting Unhealthy Practices in Pharmaceutical Purchase and Sales and Medical Services by 2026." The key points for rectifying unhealthy practices this time cover a wide range of content and have strong supervision. They not only strictly investigate various violations in pharmaceutical sales and insurance fund fraud, but also standardize the professional conduct of medical staff.

Recently, the topic of renaming Polycystic Ovary Syndrome (PCOS) has attracted widespread attention in academic and clinical fields both domestically and internationally. To objectively sort out industry consensus, coordinate naming standardization work, and take into account the pathological nature of diseases, clinical application habits, and the need for unified academic exchange at home and abroad, a special investigation was conducted on PCOS renaming. The results of this investigation and a summary of phased work are presented as follows:

Recently, the Ministry of Human Resources and Social Security, China Association for Science and Technology, Ministry of Science and Technology, and State-owned Assets Supervision and Administration Commission jointly held the selection of the 4th National Innovation Excellence Award, deciding to honor a group of advanced collectives and individuals, and to present medals, medals, or certificates respectively. On May 30th, as the tenth National Science and Technology Workers' Day approached, the fourth National Innovation Excellence Award was officially announced. This selection produced 7 teams awarded the National Innovation Excellence Medal, 26 medal recipients, and 232 certificates. Among them, in the field of obstetrics and gynecology, Professor Wang Jianliu from Peking University People's Hospital, Professor Huang Guangying from Tongji Hospital affiliated with Tongji Medical College of Huazhong University of Science and Technology, and Professor Tan Xianjie from Peking Union Medical College Hospital, Chinese Academy of Medical Sciencesand other experts were successfully selected, highlighting the innovative strength in China's field of obstetrics and gynecology.

Recently, the 38th Annual Meeting of the International Society of Gynecologic Endoscopy (ISGE) was held in Algiers, Algeria, bringing together experts from around the world in the field of minimally invasive gynecological medicine to explore cutting-edge technologies and women's health protection. The Obstetrics and Gynecology Network continues to monitor international academic trends, focusing on topics such as cervical cancer care and minimally invasive innovation. It reports on the latest achievements of Chinese experts on site, conveys China's voice, and supports in-depth exchange and collaborative development in the field of gynecology between China and abroad.

Postpartum hemorrhage is the leading cause of maternal death worldwide, and placenta previa is a "high-risk killer" for massive bleeding during cesarean sections. Recently, a large-scale Phase III clinical study led by Professor Chen Dunjin, Director of the Third Affiliated Hospital of Guangzhou Medical University / Guangzhou Institute of Obstetrics and Gynecology, jointly conducted by 24 obstetric centers nationwide, was officially published in the top international medical journal BMJ. It provides new evidence to safeguard the safety of cesarean sections for women with placenta previa: prophylactic acid use on top of routine oxytocin can reduce the incidence of postpartum bleeding from 35.1% to 29.7%, and significantly reduce the risk by 15%.

Recently, the 38th International Society of Gynecological Endoscopy (ISGE) Annual Meeting was held in Algiers, Algeria, bringing together global experts in the field of minimally invasive gynecology to explore cutting-edge technologies and women's health protection. The Obstetrics and Gynecology Network continues to pay attention to international academic trends, focusing on hot topics such as cervical cancer care and minimally invasive innovation, reporting the latest achievements of Chinese experts on the spot, conveying Chinese voices, and helping in-depth exchanges and coordinated development in the field of gynecology at home and abroad.